Form 4: MiNK Therapeutics Director Receives Stock Grant
Insider Transaction (Form 4)
John Bradley Holcomb, a Director of MiNK Therapeutics, Inc., received 1,233 shares of common stock on September 1, 2026.
Summary
- Grant/award: acquired 1,233 Common Stock at $10.95 ($13,501) on September 1, 2026; holds 4,691 after (Direct).
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as routine: the reported changes are grants, option exercises, tax withholding or similar administrative transactions, which carry limited directional signal.
Insider Transactions
John Bradley Holcomb — Director
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-09-01 | Grant/award | Common Stock | 1,233 | $11 | $13.5K | 4,691 |
Key Dates
| Date | Description |
|---|---|
| 2026-09-01 | Grant/award (1,233 shares) |
Keywords
insider transaction, Form 4, INKT, MiNK Therapeutics, Inc., neutral, John Bradley Holcomb
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.